Kaposi's sarcoma herpesvirus as a new paradigm for virus-induced oncogenesis
- PMID: 9800110
- DOI: 10.1097/00001622-199809000-00007
Kaposi's sarcoma herpesvirus as a new paradigm for virus-induced oncogenesis
Abstract
Seroepidemiologic studies show that Kaposi's sarcoma herpesvirus (KSHV) is more prevalent in those populations at higher risk to develop Kaposi's sarcoma (KS). Anti-KSHV antibody titer is also higher in those who develop KS. KSHV is a sexually transmitted disease among homosexual men, but other routes of transmission appear to be more important in Africa and Mediterranean Europe. KSHV encodes numerous cellular homologues that might be involved in KS and lymphoma pathogenesis. The characterization of these homologues provides insight into the functions of their cellular counterparts. KSHV is also unique among human herpesviruses by encoding chemokine homologues. Unlike cellular MIP1 alpha and RANTES, KSHV-chemokines are promiscuous in their receptor usage and do induce angiogenesis. They may also play a role in preventing central nervous system diseases in HIV-positive individuals.
Similar articles
-
A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.Nat Med. 1995 Jul;1(7):707-8. doi: 10.1038/nm0795-707. Nat Med. 1995. PMID: 7585156
-
Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.J Antimicrob Chemother. 2000 Apr;45 Suppl T3:15-27. doi: 10.1093/jac/45.suppl_4.15. J Antimicrob Chemother. 2000. PMID: 10855768 Review.
-
Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk.Curr Opin Oncol. 1999 Nov;11(6):508-15. doi: 10.1097/00001622-199911000-00013. Curr Opin Oncol. 1999. PMID: 10550016
-
Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.Blood. 1997 Oct 1;90(7):2826-9. Blood. 1997. PMID: 9326251
-
Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis.Immunol Res. 2013 Dec;57(1-3):159-65. doi: 10.1007/s12026-013-8458-z. Immunol Res. 2013. PMID: 24203444 Free PMC article. Review.
Cited by
-
Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.J Mol Med (Berl). 2004 Apr;82(4):223-31. doi: 10.1007/s00109-003-0519-7. Epub 2004 Jan 9. J Mol Med (Berl). 2004. PMID: 14991150 Review.
-
Classic Kaposi's sarcoma in Italy, 1985-1998.Br J Cancer. 2005 Jan 17;92(1):188-93. doi: 10.1038/sj.bjc.6602265. Br J Cancer. 2005. PMID: 15570306 Free PMC article.
-
The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.J Virol. 2012 May;86(9):5288-96. doi: 10.1128/JVI.00219-12. Epub 2012 Feb 29. J Virol. 2012. PMID: 22379101 Free PMC article.
-
A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition.J Cell Biol. 2001 Dec 24;155(7):1265-73. doi: 10.1083/jcb.200111010. Epub 2001 Dec 24. J Cell Biol. 2001. PMID: 11756476 Free PMC article.
-
A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.J Clin Invest. 2001 Jun;107(12):1599-606. doi: 10.1172/JCI12432. J Clin Invest. 2001. PMID: 11413168 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical